From NASH to HCC: current concepts and future challenges
Open accessThe DOI matches its Crossref record; 313 of the 313 references it cites were found in a registry or an index.
Abstract
Caloric excess and sedentary lifestyle have led to a global epidemic of obesity and metabolic syndrome. The hepatic consequence of metabolic syndrome and obesity, nonalcoholic fatty liver disease (NAFLD), is estimated to affect up to one-third of the adult population in many developed and developing countries. This spectrum of liver disease ranges from simple steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. Owing to the high prevalence of NAFLD, especially in industrialized countries but also worldwide, and the consequent burden of progressive liver disease, there is mounting epidemiological evidence that NAFLD has rapidly become a leading aetiology underlying many cases of hepatocellular carcinoma (HCC). In this Review, we discuss NAFLD-associated HCC, including its epidemiology, the key features of the hepatic NAFLD microenvironment (for instance, adaptive and innate immune responses) that promote hepatocarcinogenesis and the management of HCC in patients with obesity and associated metabolic comorbidities. The challenges and future directions of research will also be discussed, including clinically relevant biomarkers for early detection, treatment stratification and monitoring as well as approaches to therapies for both prevention and treatment in those at risk or presenting with NAFLD-associated HCC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
1 retracted
Items 201–313 of 313
ATM and the Molecular Pathogenesis of Ataxia Telangiectasia
McKinnon, P. J. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132509 · Cited by 240
Wu, J., Li, J., Salcedo, R., Mivechi, N. F., Trinchieri, G., & Horuzsko, A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0938 · Cited by 238
Gerber, L., Otgonsuren, M., Mishra, A., Escheik, C., Birerdinc, A., Stepanova, M., & Younossi, Z. M. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12038 · Cited by 234
Teufel, A., Itzel, T., Erhart, W., Brosch, M., Wang, X. Y., Kim, Y. O., von Schönfels, W., Herrmann, A., Brückner, S., Stickel, F., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.05.051 · Cited by 229
Extracellular Vesicles in Liver Pathobiology: Small Particles With Big Impact
Hirsova, P., Ibrahim, S. H., Verma, V. K., Morton, L. A., Shah, V. H., LaRusso, N. F., Gores, G. J., & Malhi, H. (2016) · Hepatology · doi:10.1002/hep.28814 · Cited by 229
Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice
McCuskey, R. S., Ito, Y., Robertson, G. R., McCuskey, M. K., Perry, M., & Farrell, G. C. (2004) · Hepatology · doi:10.1002/hep.20302 · Cited by 210
Failure Rates in the Hepatocellular Carcinoma Surveillance Process
Singal, A. G., Yopp, A. C., Gupta, S., Skinner, C. S., Halm, E. A., Okolo, E., Nehra, M., Lee, W. M., Marrero, J. A., & Tiro, J. A. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0046 · Cited by 208
DNA Damage in Inflammation-Related Carcinogenesis and Cancer Stem Cells
Ohnishi, S., Ma, N., Thanan, R., Pinlaor, S., Hammam, O., Murata, M., & Kawanishi, S. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/387014 · Cited by 207
Inhibition of De Novo NAD + Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage
Tummala, K. S., Gomes, A. L., Yilmaz, M., Graña, O., Bakiri, L., Ruppen, I., Ximénez-Embún, P., Sheshappanavar, V., Rodriguez-Justo, M., Pisano, D. G., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.002 · Cited by 206
Mishra, S. I., Scherer, R. W., Snyder, C., Geigle, P. M., Berlanstein, D. R., & Topaloglu, O. (2012) · Clinical Otolaryngology · doi:10.1111/coa.12015 · Cited by 206
Kechagias, S., Ernersson, Å., Dahlqvist, O., Lundberg, P., Lindström, T., Nystrom, F. H., & for the Fast Food Study Group (2008) · Gut · doi:10.1136/gut.2007.131797 · Cited by 201
Surveillance, Diagnosis, Treatment, and Outcome of Liver Cancer in Japan
Kudo, M. (2015) · Liver Cancer · doi:10.1159/000367727 · Cited by 198
Yuan, D., Huang, S., Berger, E., Liu, L., Gross, N., Heinzmann, F., Ringelhan, M., Connor, T. O., Stadler, M., Meister, M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.006 · Cited by 197
Predicting Hepatocellular Carcinoma by Detection of Aberrant Promoter Methylation in Serum DNA
Zhang, Y.-J., Wu, H.-C., Shen, J., Ahsan, H., Tsai, W. Y., Yang, H.-I., Wang, L.-Y., Chen, S.-Y., Chen, C.-J., & Santella, R. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1900 · Cited by 191
Non‐alcoholic steatohepatitis: Definitions and pathogenesis
DAY, C., & SAKSENA, S. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s3.31.x · Cited by 185
The innate immune response during liver inflammation and metabolic disease
Bieghs, V., & Trautwein, C. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.04.005 · Cited by 175
Stickel, F., & Hellerbrand, C. (2010) · Gut · doi:10.1136/gut.2009.199661 · Cited by 174
Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
Nakagawa, H., Hayata, Y., Kawamura, S., Yamada, T., Fujiwara, N., & Koike, K. (2018) · Cancers · doi:10.3390/cancers10110447 · Cited by 174
NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma
Wilson, C. L., Jurk, D., Fullard, N., Banks, P., Page, A., Luli, S., Elsharkawy, A. M., Gieling, R. G., Chakraborty, J. B., Fox, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms7818 · Cited by 171
Mantovani, A., & Targher, G. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.04.41 · Cited by 167
Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD
Reeves, H. L., Zaki, M. Y. W., & Day, C. P. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4085-6 · Cited by 166
Self-citationThe Role of Diet and Nutrient Composition in Nonalcoholic Fatty Liver Disease
McCarthy, E. M., & Rinella, M. E. (2012) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jada.2011.10.007 · Cited by 162
The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2
Day, C., & Anstee, Q. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562947 · Cited by 161
Self-citationSun, Y.-F., Guo, W., Xu, Y., Shi, Y.-H., Gong, Z.-J., Ji, Y., Du, M., Zhang, X., Hu, B., Huang, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1063 · Cited by 161
Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond
Raoul, J., Kudo, M., Finn, R. S., Edeline, J., Reig, M., & Galle, P. R. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.05.006 · Cited by 161
Boyle, M., Masson, S., & Anstee, Q. M. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.006 · Cited by 159
Self-citationKalinich, M., Bhan, I., Kwan, T. T., Miyamoto, D. T., Javaid, S., LiCausi, J. A., Milner, J. D., Hong, X., Goyal, L., Sil, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617032114 · Cited by 155
Boege, Y., Malehmir, M., Healy, M. E., Bettermann, K., Lorentzen, A., Vucur, M., Ahuja, A. K., Böhm, F., Mertens, J. C., Shimizu, Y., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.010 · Cited by 154
Self-citationHepatic glucose sensing is required to preserve β cell glucose competence
Seyer, P., Vallois, D., Poitry-Yamate, C., Schütz, F., Metref, S., Tarussio, D., Maechler, P., Staels, B., Lanz, B., Grueter, R., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65538 · Cited by 148
Diagnosis and Assessment of NAFLD: Definitions and Histopathological Classification
Lackner, C., Tiniakos, D., & Burt, A. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562942 · Cited by 145
Reid, D. T., Reyes, J. L., McDonald, B. A., Vo, T., Reimer, R. A., & Eksteen, B. (2016) · PLOS ONE · doi:10.1371/journal.pone.0159524 · Cited by 145
Ogle, L. F., Orr, J. G., Willoughby, C. E., Hutton, C., McPherson, S., Plummer, R., Boddy, A. V., Curtin, N. J., Jamieson, D., & Reeves, H. L. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.014 · Cited by 144
Self-citationGao, D., Wei, C., Chen, L., Huang, J., Yang, S., & Diehl, A. M. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00228.2004 · Cited by 141
Submaximal cardiopulmonary exercise testing predicts 90-day survival after liver transplantation
Prentis, J. M., Manas, D. M. D., Trenell, M. I., Hudson, M., Jones, D. J., & Snowden, C. P. (2012) · Liver Transplantation · doi:10.1002/lt.22426 · Cited by 136
Govaere, O., Wouters, J., Petz, M., Vandewynckel, Y.-P., Van den Eynde, K., Van den broeck, A., Verhulst, S., Dollé, L., Gremeaux, L., Ceulemans, A., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.011 · Cited by 136
Self-citationImplication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
Boursier, J., & Diehl, A. M. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004559 · Cited by 132
Novel Insights into the Pathophysiology of Nonalcoholic Fatty Liver Disease
Feldstein, A. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1267539 · Cited by 130
Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma
Tangkijvanich, P., Hourpai, N., Rattanatanyong, P., Wisedopas, N., Mahachai, V., & Mutirangura, A. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.12.029 · Cited by 130
Dietary glycemic index and liver steatosis
Valtueña, S., Pellegrini, N., Ardigò, D., Rio, D. D., Numeroso, F., Scazzina, F., Monti, L. D., Zavaroni, I., & Brighenti, F. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.136 · Cited by 129
Pais, R., Fartoux, L., Goumard, C., Scatton, O., Wendum, D., Rosmorduc, O., & Ratziu, V. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14261 · Cited by 129
The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease
Perla, F., Prelati, M., Lavorato, M., Visicchio, D., & Anania, C. (2017) · Children · doi:10.3390/children4060046 · Cited by 127
Serum Immunoglobulin Levels Predict Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
McPherson, S., Henderson, E., Burt, A. D., Day, C. P., & Anstee, Q. M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.010 · Cited by 124
Self-citationFarnesoid X receptor: A “homeostat” for hepatic nutrient metabolism
Massafra, V., & van Mil, S. W. C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.003 · Cited by 122
Degirolamo, C., Modica, S., Vacca, M., Di Tullio, G., Morgano, A., D'Orazio, A., Kannisto, K., Parini, P., & Moschetta, A. (2015) · Hepatology · doi:10.1002/hep.27274 · Cited by 121
Petrelli, A., Perra, A., Cora, D., Sulas, P., Menegon, S., Manca, C., Migliore, C., Kowalik, M. A., Ledda-Columbano, G. M., Giordano, S., et al. (2014) · Hepatology · doi:10.1002/hep.26616 · Cited by 121
Wen, C.-P., Lin, J., Yang, Y. C., Tsai, M. K., Tsao, C. K., Etzel, C., Huang, M., Hsu, C. Y., Ye, Y., Mishra, L., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs372 · Cited by 120
Fatty liver diseases, bile acids, and FXR
Zhu, Y., Liu, H., Zhang, M., & Guo, G. L. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.07.008 · Cited by 118
Stickel, F., Buch, S., Nischalke, H. D., Weiss, K. H., Gotthardt, D., Fischer, J., Rosendahl, J., Marot, A., Elamly, M., Casper, M., et al. (2018) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0041-8 · Cited by 118
Tanaka, S., Miyanishi, K., Kobune, M., Kawano, Y., Hoki, T., Kubo, T., Hayashi, T., Sato, T., Sato, Y., Takimoto, R., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-012-0739-0 · Cited by 116
p62/SQSTM 1—Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer
Taniguchi, K., Yamachika, S., He, F., & Karin, M. (2016) · FEBS Letters · doi:10.1002/1873-3468.12301 · Cited by 112
Hallsworth, K., Thoma, C., Moore, S., Ploetz, T., Anstee, Q. M., Taylor, R., Day, C. P., & Trenell, M. I. (2015) · Frontline Gastroenterology · doi:10.1136/flgastro-2014-100432 · Cited by 108
Self-citationCalle, E. E. (2007) · BMJ · doi:10.1136/bmj.39384.472072.80 · Cited by 107
Associations between dietary factors and markers of NAFLD in a general Dutch adult population
Rietman, A., Sluik, D., Feskens, E. J. M., Kok, F. J., & Mensink, M. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.148 · Cited by 102
Seydel, G. Ş., Kücükoglu, Ö., Altinbasv, A., Demir, O. O., Yılmaz, S., Akkız, H., Otan, E., Sowa, J., & Canbay, A. E. (2016) · PubMed · doi:10.5604/16652681.1212316 · Cited by 98
Ikawa‐Yoshida, A., Matsuo, S., Kato, A., Ohmori, Y., Higashida, A., Kaneko, E., & Matsumoto, M. (2017) · International Journal of Experimental Pathology · doi:10.1111/iep.12240 · Cited by 98
Teoh, N., Dan, Y. Y., Swisshelm, K. L., Lehman, S. L., Wright, J. H., Haque, J. A., Gu, Y., & Fausto, N. (2008) · Hepatology · doi:10.1002/hep.22194 · Cited by 97
p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA
Xu, L.-Z., Li, S.-S., Zhou, W., Kang, Z.-J., Zhang, Q.-X., Kamran, M., Xu, J., Liang, D.-P., Wang, C.-L., Hou, Z.-J., et al. (2017) · Oncogene · doi:10.1038/onc.2016.202 · Cited by 94
Denda, A., Kitayama, W., Kishida, H., Murata, N., Tsutsumi, M., Tsujiuchi, T., Nakae, D., & Konishi, Y. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01250.x · Cited by 93
Gustafson, M. P., DiCostanzo, A. C., Wheatley, C. M., Kim, C.-H., Bornschlegl, S., Gastineau, D. A., Johnson, B. D., & Dietz, A. B. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0231-8 · Cited by 93
Oxidative stress parameters in paediatric non-alcoholic fatty liver disease
Nobili (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000487 · Cited by 92
The Challenge for Development of Valuable Immuno-oncology Biomarkers
Mehnert, J. M., Monjazeb, A. M., Beerthuijzen, J. M. T., Collyar, D., Rubinstein, L., & Harris, L. N. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3063 · Cited by 92
Bile Acid Receptors and Liver Cancer
Wang, X., Fu, X., Van Ness, C., Meng, Z., Ma, X., & Huang, W. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-012-0003-6 · Cited by 91
Role of FXR in Liver Inflammation During Nonalcoholic Steatohepatitis
Armstrong, L. E., & Guo, G. L. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0085-2 · Cited by 90
Nrf2, but not β‐catenin, mutation represents an early event in rat hepatocarcinogenesis
Zavattari, P., Perra, A., Menegon, S., Kowalik, M. A., Petrelli, A., Angioni, M. M., Follenzi, A., Quagliata, L., Ledda‐Columbano, G. M., Terracciano, L., et al. (2015) · Hepatology · doi:10.1002/hep.27790 · Cited by 88
Cornell, L., Munck, J. M., Alsinet, C., Villanueva, A., Ogle, L., Willoughby, C. E., Televantou, D., Thomas, H. D., Jackson, J., Burt, A. D., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0842 · Cited by 87
Self-citationSeko, Y., Sumida, Y., Tanaka, S., Mori, K., Taketani, H., Ishiba, H., Hara, T., Okajima, A., Umemura, A., Nishikawa, T., et al. (2017) · Hepatology Research · doi:10.1111/hepr.12840 · Cited by 84
Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota
Wahlström, A., Kovatcheva-Datchary, P., Ståhlman, M., Khan, M.-T., Bäckhed, F., & Marschall, H.-U. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m072819 · Cited by 84
Daugherity, E. K., Balmus, G., Al Saei, A., Moore, E. S., Abi Abdallah, D., Rogers, A. B., Weiss, R. S., & Maurer, K. J. (2012) · Cell Cycle · doi:10.4161/cc.20259 · Cited by 81
URI Is an Oncogene Amplified in Ovarian Cancer Cells and Is Required for Their Survival
Theurillat, J.-P. P., Metzler, S. C., Henzi, N., Djouder, N., Helbling, M. M., Zimmermann, A.-K., Jacob, F., Soltermann, A., Caduff, R. F., Heinzelmann-Schwarz, V. A., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.019 · Cited by 81
Nishida, N., Yada, N., Hagiwara, S., Sakurai, T., Kitano, M., & Kudo, M. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13318 · Cited by 79
Wang, Y., Ausman, L. M., Greenberg, A. S., Russell, R. M., & Wang, X. (2009) · International Journal of Cancer · doi:10.1002/ijc.23995 · Cited by 76
Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration
Li, G., & L. Guo, G. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.01.005 · Cited by 75
Liver cancer biopsy – back to the future?!
Torbenson, M. S., & Schirmacher, P. (2015) · Hepatology · doi:10.1002/hep.27545 · Cited by 72
Circulating tumour cells and cell-free DNA in gastrointestinal cancer
Pantel, K., & Alix‐Panabières, C. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.198 · Cited by 72
Li, J., Chen, L., Zhang, X., Zhang, Y., Liu, H., Sun, B., Zhao, L., Ge, N., Qian, H., Yang, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096185 · Cited by 70
Circulating biomarkers in hepatocellular carcinoma
Morris, K. L., Tugwood, J. D., Khoja, L., Lancashire, M., Sloane, R. A. S., Burt, D., Shenjere, P., Zhou, C., Hodgson, C., Ohtomo, T., et al. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2508-7 · Cited by 68
Single cell polarity in liquid phase facilitates tumour metastasis
Lorentzen, A., Becker, P. F., Kosla, J., Saini, M., Weidele, K., Ronchi, P., Klein, C., Wolf, M. J., Geist, F., Seubert, B., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03139-6 · Cited by 62
Lanthier, N. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i19.2184 · Cited by 60
Ehrhardt, N., Doche, M. E., Chen, S., Mao, H. Z., Walsh, M. T., Bedoya, C., Guindi, M., Xiong, W., Ignatius Irudayam, J., Iqbal, J., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx159 · Cited by 60
Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook
Ng, C. K. Y., Costanzo, G. G. D., Terracciano, L., & Piscuoglio, S. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00078 · Cited by 60
La Autoantigen Mediates Oxidant Induced De Novo Nrf2 Protein Translation
Zhang, J. Y., Dinh, T. N., Kappeler, K. V., Tsaprailis, G., & Chen, Q. M. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.015032 · Cited by 59
Evert, M., Frau, M., Tomasi, M. L., Latte, G., Simile, M. M., Seddaiu, M. A., Zimmermann, A., Ladu, S., Staniscia, T., Brozzetti, S., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.606 · Cited by 58
Surveillance for Hepatocellular Carcinoma
Corte, C. D., & Colombo, M. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.05.002 · Cited by 58
Endogenous bile acids as carcinogens
Jansen, P. L. M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.06.001 · Cited by 57
Fautrel, A., Andrieux, L. O., Musso, O. C., Boudjéma, K., Guillouzo, A., & Langouët, S. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.020 · Cited by 57
Li, J., Shi, L., Zhang, X., Sun, B., Yang, Y., Ge, N., Liu, H., Yang, X., Chen, L., Qian, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6104 · Cited by 55
Pardo, F., Sangro, B., Lee, R., Manas, D., Jeyarajah, R., Donckier, V., Maleux, G. A., Pinna, A. D., Bester, L., Morris, D. L., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-5950-z · Cited by 53
Liu, Y.-L., Patman, G. L., Leathart, J. B. S., Piguet, A. C., Burt, A. D., Dufour, J.-F., Day, C. P., Daly, A. K., Reeves, H. L., & Anstee, Q. M. (n.d.) · Open Access CRIS of the University of Bern · doi:10.7892/boris.67130 · Cited by 50
Self-citationDevelopment of FXR, PXR and CAR Agonists and Antagonists for Treatment of Liver Disorders
Fiorucci, S., Zampella, A., & Distrutti, E. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612799436678 · Cited by 48
Taylor, E. J., Jones, R. L., Guthrie, J. A., & Rowe, I. A. (2017) · Hepatology · doi:10.1002/hep.29315 · Cited by 46
Lenvatinib in Advanced Hepatocellular Carcinoma
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000479573 · Cited by 46
Biopsy for liver cancer: How to balance research needs with evidence‐based clinical practice
Sherman, M., & Bruix, J. (2014) · Hepatology · doi:10.1002/hep.27563 · Cited by 43
mTOR at the Transmitting and Receiving Ends in Tumor Immunity
Guri, Y., Nordmann, T. M., & Roszik, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00578 · Cited by 42
Immune Checkpoint Blockade in Hepatocellular Carcinoma
Liu, G.-J., Wang, W., Lu, M.-D., Xie, X.-Y., Xu, H.-X., Xu, Z.-F., Chen, L.-D., Wang, Z., Liang, J.-Y., Huang, Y., et al. (2015) · Liver Cancer · doi:10.1159/000367758 · Cited by 41
Pleiotropic functions of bile acids mediated by the farnesoid X receptor.
Stanimirov, B., Stankov, K., & Mikov, M. (2012) · PubMed · Cited by 40
Schults, M. A., Nagle, P. W., Rensen, S. S., Godschalk, R., Munnia, A., Peluso, M. E. M., Claessen, S. M. H., Greve, J. W. M., Driessen, A. L. C., Verdam, F. J., et al. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.11.001 · Cited by 38
Arbelaiz, A., Azkargorta, M., Santos‐Laso, Á., Perugorria, M. J., Erice, O., González, E., Lapitz, A., Izquierdo‐Sánchez, L., Olaizola, P., Lee, P. Y., et al. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)30712-2 · Cited by 34
DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma?
Pascale, R. M., Joseph, C., Latte, G., Evert, M., Feo, F., & Calvisi, D. F. (2016) · DNA repair · doi:10.1016/j.dnarep.2016.10.004 · Cited by 32
Prognostic value of DNA repair based stratification of hepatocellular carcinoma
Lin, Z., Xu, S., Wang, H., Cai, Y., Li, Y., Song, M. L., Wang, Y.-Q., Du, S.-J., Shi, K., & Zhou, M. (2016) · Scientific Reports · doi:10.1038/srep25999 · Cited by 30
1047 KERATIN 19: A KEY ROLE PLAYER IN THE INVASION OF HUMAN HEPATOCELLULAR CARCINOMAS
Govaere, O., Komuta, M., Berkers, J., Spee, B., Janssen, C., de Luca, F., Katoonizadeh, A., Wouters, J., van Kempen, L. C. L. T., Durnez, A., et al. (2013) · Journal of Hepatology · doi:10.1016/s0168-8278(13)61048-x · Cited by 29
Self-citationInverted diurnal rhythm of cellular autophagy in liver cells of rats fed a single daily meal
Pfeifer, U. (1972) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02899710 · Cited by 28
Survey of health status, nutrition and geography of food selection of chronic liver disease patients
Leslie, T., Pawloski, L., Kallman-Price, J., Escheik, C., Hossain, N., Fang, Y., Gerber, L. H., & Younossi, Z. M. (2014) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31253-0 · Cited by 28
Assessment of the Hong Kong Liver Cancer Staging System in Europe
Kolly, P., Reeves, H. L., Sangro, B., Knöpfli, M., Candinas, D., & Dufour, J. (2015) · Liver International · doi:10.1111/liv.13045 · Cited by 27
Self-citationAnimal Models Correlating Immune Cells for the Development of NAFLD/NASH
Iyer, S., Upadhyay, P. K., Majumdar, S. S., & Nagarajan, P. (2015) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2015.06.004 · Cited by 26
Hwang, A., Shi, C., Zhu, E. Y., Naaz, F., Zhou, P., Rasheed, Z., Liu, X., Jung, L., Duan, B., Li, J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198937 · Cited by 24
Mishra, A., Otgonsuren, M., Stepanova, M., Esceik, C., Gerber, L. H., & Younossi, Z. M. (2012) · Journal of Hepatology · doi:10.1016/s0168-8278(12)61344-0 · Cited by 21
Kirstein, M. M., Schweitzer, N., Winter, T., Lappas, K., Graen, N., Kunstmann, I., Voigtländer, T., Reineke‐Plaaß, T., Manns, M. P., Lehner, F., et al. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13761 · Cited by 21
Selective internal radiation therapy for liver malignancies
Moir, J. A. G., Burns, J., Barnes, J., Colgan, F. E., White, S. A., Littler, P., Manas, D., & French, J. (2015) · British journal of surgery · doi:10.1002/bjs.9924 · Cited by 13
Morling, J. R., Fallowfield, J. A., Guha, I. N., Williamson, R. M., Ali, M., Glancy, S., Strachan, M. W. J., & Price, J. F. (2015) · QJM · doi:10.1093/qjmed/hcv191 · Cited by 13
Malehmir, M., Pfister, D. R., Gallage, S., Szydlowska, M., Inverso, D., Kotsiliti, E., Leone, V., Peiseler, M., Surewaard, B. G. J., Rath, D., et al. (2019) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0038-1677172 · Cited by 13
Self-citationRole of Class II Nuclear Receptors in Liver Carcinogenesis
Li, G., & Guo, G. L. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011796011064 · Cited by 12
Hepatocellular Carcinoma in Obesity: Finding a Needle in the Haystack?
Baffy, G. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_6 · Cited by 7
Exercise: A new role for an old tool
Idorn, M., & Straten, P. T. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2016.1163005 · Cited by 5
Cited by
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
“TLR4 signaling in macrophages and stellate cells, for example, provokes inflammasome activation in both cell types, which is proinflammatory and fibrogenic (Anstee et al., 2019; Dong et al., 2020; Nguyen et al., 2018; Sharifnia et al., 2015).”
BackgroundImmunotherapies for hepatocellular carcinoma
Llovet, J. M., Castet, F., Heikenwalder, M., Maini, M. K., Mazzaferro, V., Pinato, D. J., Pikarsky, E., Zhu, A. X., & Finn, R. S. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00573-2 · Cited by 1,843
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Pfister, D., Núñez, N. G., Pinyol, R., Govaere, O., Pinter, M., Szydlowska, M., Gupta, R., Qiu, M., Deczkowska, A., Weiner, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03362-0 · Cited by 1,294
Self-citationFerroptosis in cancer: from molecular mechanisms to therapeutic strategies
Zhou, Q., Meng, Y., Li, D., Yao, L., Le, J., Liu, Y., Sun, Y., Zeng, F., Chen, X., & Deng, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01769-5 · Cited by 890
“472,473 A recent study has revealed that ferroptosis stands out as the most pertinent form of hepatocyte death, leading to HCC-promoting necroin fl ammation and compensatory proliferation.”
Background
Metadata
- Authors
- Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M.
- Affiliations
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- German Cancer Research Center (DE)
- Newcastle University (GB)
- Corresponding author
- Anstee, Quentin M.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2019-04-26
- Volume
- 16
- Issue
- 7
- Pages
- 411-428
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2941033601
- Semantic Scholar
- ecc5c12857f3a9c6f4fcd2e4d5b2b14dfa67257d
- Cited by
- 1,392
- References
- 313
- Citations by year
- 2026: 119 · 2025: 157 · 2024: 208 · 2023: 240 · 2022: 251 · 2021: 236 · 2020: 148 · 2019: 32
- FWCI
- 21.91
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Cancer Research UK (26813, 23390)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- non-alcoholic fatty liver disease, hepatocellular carcinoma, nonalcoholic steatohepatitis, obesity, metabolic syndrome, hepatocarcinogenesis, liver microenvironment, immune response, biomarkers, early detection, liver cirrhosis
- MeSH terms
- Carcinoma, Hepatocellular, Humans, Liver, Liver Neoplasms, Morbidity, Risk Factors, Global Health, Disease Progression, Tumor Microenvironment, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.